LY 517717 is a coagulation factor Xa inhibitor potentially for the treatment of venous thromboembolism (VTE). References: Agnelli G, Haas S, Ginsberg JS, Krueger KA, Dmitrienko A, Brandt JT. A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement. J Thromb Haemost. 2007 Apr;5(4):746-53. PubMed PMID: 17408408.

纯度：≥98%

CAS：313489-71-3